Literature DB >> 27748937

Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis.

Xiu-Bo Sang1, Kai-Xuan Sun1, Li-Li Wang1, Shuo Chen1, Dan-Dan Wu1, Zhi-Hong Zong2, Yang Zhao3.   

Abstract

Cancer stem cells are considered to be the root cause of tumor initiation, metastasis, recurrence and therapeutic resistance. Recent studies have reported that RhoC plays a critical role in regulating cancer stem cells; however, its function in ovarian cancer stem cells (OCSCs) remains unknown. The ovarian cancer cell line A2780, and the paclitaxel-resistant A2780 cell line (A2780-PTX) were obtained. A2780 cells were used to isolate and identify the highly invasive A2780-PM cells, and A2780-PTX cells were used to isolate and identify the highly drug-resistant and highly invasive A2780-PTX-PM cells by Transwell assay. MTT, Transwell and wound healing assays were used to compare the differences in cell proliferation, invasion and migration ability among the four cell lines. Immunofluorescence was used to detect the expression of stem cell markers CD117 and CD133. OCSCs were sorted by flow cytometry. Following si-RhoC transfection of the OCSCs, cell proliferation, drug resistance, invasion and migration ability and RhoC, CD117 and CD133 expression levels were assayed. RT-PCR was used to assess RhoC, CD117, CD133 and matrix metalloproteinase 9 (MMP9) mRNA expression levels. A2780-PM and A2780‑PTX-PM cells exhibited higher cell proliferation, drug resistance, and invasion and migration ability than the A2780 and A2780-PTX cell lines. Furthermore, CD133 and CD117 expression levels were higher in the A2780-PM and A2780‑PTX-PM cells than levels in the A2780 and A2780-PTX cells. Transfection of si-RhoC in OCSCs suppressed the proliferation, drug resistance, invasion, migration and CD117 and CD133 expression levels. Furthermore, the expression levels of RhoC, CD117, CD133, MDR1, and MMP9 mRNA were downregulated in the transfected population. Taken together, our results demonstrated that RhoC downregulation may inhibit the proliferation, drug resistance, invasion and migration of OCSCs, and RhoC may play an important role in the formation of OCSCs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27748937     DOI: 10.3892/or.2016.5164

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

Review 1.  Research Progresses in Cancer Stem Cells of Three Common Fertility-Related Female Malignancies.

Authors:  Xi-Ping Zhang; Qi-Hui Cheng; Hong-Jian Yang; En-Qi Qiao
Journal:  Pathol Oncol Res       Date:  2018-07-17       Impact factor: 3.201

2.  Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway.

Authors:  Hongying Liu; Gang Wang; Lili Yang; Jianjun Qu; Zhihui Yang; Xiangyu Zhou
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

3.  RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.

Authors:  Annapurna Pranatharthi; Pavana Thomas; Avinash H Udayashankar; Chandra Bhavani; Srinag Bangalore Suresh; Sudhir Krishna; Jayashree Thatte; Nirmala Srikantia; Cecil R Ross; Sweta Srivastava
Journal:  J Exp Clin Cancer Res       Date:  2019-09-05

4.  TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer.

Authors:  Jiahui Xu; Xiaoli Yang; Qiaodan Deng; Cong Yang; Dong Wang; Guojuan Jiang; Xiaohong Yao; Xueyan He; Jiajun Ding; Jiankun Qiang; Juchuanli Tu; Rui Zhang; Qun-Ying Lei; Zhi-Min Shao; Xiuwu Bian; Ronggui Hu; Lixing Zhang; Suling Liu
Journal:  Nat Commun       Date:  2021-07-20       Impact factor: 14.919

5.  OCT4 accelerates tumorigenesis through activating JAK/STAT signaling in ovarian cancer side population cells.

Authors:  Zhengyi Ruan; Xingyu Yang; Weiwei Cheng
Journal:  Cancer Manag Res       Date:  2018-12-28       Impact factor: 3.989

6.  Changes in Biomechanical Properties of A375 Cells Due to the Silencing of TMSB4X Expression Are Not Directly Correlated with Alterations in Their Stemness Features.

Authors:  Aleksandra Makowiecka; Ewa Mazurkiewicz; Ewa Mrówczyńska; Natalia Malek; Alice Battistella; Marco Lazzarino; Dorota Nowak; Antonina Joanna Mazur
Journal:  Cells       Date:  2021-03-31       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.